INVESTER I ADVICENNE SACA MED ENDAVU: Køb Advicenne SACA ($ALDVI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Advicenne SACA, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Advicenne S.A. is a specialty pharmaceutical company focused on developing and commercializing treatments for rare renal diseases and selected neurological conditions. Its current portfolio includes Sibnayal for metabolic disorders linked to kidney-related rare diseases, as well as Likozam, a clobazam formulation, and Levidcen, a levetiracetam-based treatment for epileptic seizures. The company serves patients across pediatric and adult care settings, with an emphasis on orphan diseases that require tailored therapeutic solutions. Headquartered in Paris, France, Advicenne operates in France and internationally, where it contributes to the niche market for specialized medicines in nephrology and neurology.